Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Bruckert

Showing results (11-20 of 235) with videos related to

Pageof 24
Sort By:
European Journal of Preventive Cardiology|September 28, 2017
Is lomitapide a life-saving drug in homozygous familial hypercholesterolemiaEric Bruckert, Antonio Gallo
Lancet (London, England)|December 4, 2003
Prevention campaigns for cardiovascular diseaseEric Bruckert, John Chapman
European Journal of Preventive Cardiology|July 18, 2012
Implementation, target population, compliance and barriers to risk guided therapyLale Tokgozoglu, Eric Bruckert
Preventive Medicine|February 10, 2004
Educational level has a major impact on the representations of cholesterol: a study in 1579 hypercholesterolemic patientsSilla M Consoli, Eric Bruckert
The British Journal of Nutrition|June 5, 2010
n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendationsSébastien Czernichow, Daniel Thomas, Eric Bruckert
Circulation|July 2, 2003
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorptionEric Bruckert, Philippe Giral, Philippe Tellier
Current Opinion in Cardiology|August 9, 2012
Is a cardioprotective action of alcohol a myth?Boris Hansel, Anatol Kontush, Eric Bruckert
Current Opinion in Endocrinology, Diabetes, and Obesity|December 5, 2020
Advances in the management of statin myopathyAntonio Gallo, Jeff Perregaux, Eric Bruckert
Circulation|May 30, 2002
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemiaClaude Gagné, Daniel Gaudet, Eric Bruckert, et al.
Atherosclerosis|January 19, 2010
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisEric Bruckert, Julien Labreuche, Pierre Amarenco
Pageof 24

Showing results (11-20 of 235) with videos related to

Sort By:
Pageof 24
European Journal of Preventive Cardiology|September 28, 2017
Is lomitapide a life-saving drug in homozygous familial hypercholesterolemiaEric Bruckert, Antonio Gallo
Lancet (London, England)|December 4, 2003
Prevention campaigns for cardiovascular diseaseEric Bruckert, John Chapman
European Journal of Preventive Cardiology|July 18, 2012
Implementation, target population, compliance and barriers to risk guided therapyLale Tokgozoglu, Eric Bruckert
Preventive Medicine|February 10, 2004
Educational level has a major impact on the representations of cholesterol: a study in 1579 hypercholesterolemic patientsSilla M Consoli, Eric Bruckert
The British Journal of Nutrition|June 5, 2010
n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendationsSébastien Czernichow, Daniel Thomas, Eric Bruckert
Circulation|July 2, 2003
Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorptionEric Bruckert, Philippe Giral, Philippe Tellier
Current Opinion in Cardiology|August 9, 2012
Is a cardioprotective action of alcohol a myth?Boris Hansel, Anatol Kontush, Eric Bruckert
Current Opinion in Endocrinology, Diabetes, and Obesity|December 5, 2020
Advances in the management of statin myopathyAntonio Gallo, Jeff Perregaux, Eric Bruckert
Circulation|May 30, 2002
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemiaClaude Gagné, Daniel Gaudet, Eric Bruckert, et al.
Atherosclerosis|January 19, 2010
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisEric Bruckert, Julien Labreuche, Pierre Amarenco
Pageof 24